These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1011 related articles for article (PubMed ID: 14613268)

  • 1. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
    Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
    Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
    Valle Y; Ledezma-Lozano IY; Torres-Carrillo N; Padilla-Gutiérrez JR; Navarro-Hernández RE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Armendáriz-Borunda J; Muñoz-Valle JF
    Scand J Rheumatol; 2009; 38(5):332-5. PubMed ID: 19579138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR; Dawes PT; Nixon NB; Mattey DL
    Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.
    Glossop JR; Nixon NB; Dawes PT; Hassell AB; Mattey DL
    J Rheumatol; 2003 Jul; 30(7):1406-9. PubMed ID: 12858434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis.
    Shibue T; Tsuchiya N; Komata T; Matsushita M; Shiota M; Ohashi J; Wakui M; Matsuta K; Tokunaga K
    Arthritis Rheum; 2000 Apr; 43(4):753-7. PubMed ID: 10765919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor necrosis factor-alpha and kidney damage in rheumatoid arthritis].
    Tsybul'ko SV; Baranov AA; Borodin AG; Korshunov NI; Kirdianov SIu
    Ter Arkh; 2001; 73(5):8-11. PubMed ID: 11517757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Florczak M; Ostanek L; Brzosko M; Brzosko I; Szklarz BG
    Scand J Rheumatol; 2005; 34(1):22-6. PubMed ID: 15903021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised circulating interleukin-18 levels in reactive AA-amyloidosis.
    Maury CP; Tiitinen S; Laiho K; Kaarela K; Liljeström M
    Amyloid; 2002 Jun; 9(2):141-4. PubMed ID: 12440487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
    Glossop JR; Dawes PT; Hassell AB; Mattey DL
    J Rheumatol; 2005 Sep; 32(9):1673-8. PubMed ID: 16142859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
    Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
    J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
    Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
    Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
    Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
    J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.
    Cuchacovich M; Ferreira L; Aliste M; Soto L; Cuenca J; Cruzat A; Gatica H; Schiattino I; Pérez C; Aguirre A; Salazar-Onfray F; Aguillón JC
    Scand J Rheumatol; 2004; 33(4):228-32. PubMed ID: 15370717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility.
    Teramoto M; Kitawaki J; Koshiba H; Kitaoka Y; Obayashi H; Hasegawa G; Nakamura N; Yoshikawa T; Matsushita M; Maruya E; Saji H; Ohta M; Honjo H
    Am J Reprod Immunol; 2004 May; 51(5):352-7. PubMed ID: 15212671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.